Drs. Shivani Singh and Leopoldo Segal Discuss a Metagenomics Revolution in #Bronchiectasis in ATS Blue Journal

🔓 bit.ly/3UFzsFM
#PCCM #Lungdisease #lung #microbiome

Intratumoral immunotherapy can reinvigorate anti-tumor immune responses in patients with advanced NSCLC refractory to checkpoint inhibitors. Remarkable advance worthy of study in a future definitive RCT! #ASCO2024 Charu Aggarwal, MD, MPH, FASCO

Save the Date for the 1st North American #Bronchiectasis & #NTM Symposium, a forum that explores real-world challenges & complexities of bronchiectasis/NTM management.

📆 Monday-Tuesday December 9-10, 2024
📍 In Person NYU Langone Health & virtual
🔗 bit.ly/44yduck

Fantastic work by Kenna Pollard, MPH and Dr. David Kaufman detailing the inadequacy of peripheral VBGs in management of critically ill patients! ⁦NYULangonePCCSM⁩ #ATS2024

Research making news at #ATS2024 via NBC News: Former cigarette smokers who vape more likely to get lung cancer: study
nbcrightnow.com/lifestyles/hea…

Before we wrap up American Thoracic Society (ATS) #ATS2024 , we have sessions on #Lungtransplant #Lungcancer , #Asthma , #COVID19 and more!

As the conference ends, we want towish everyone a safe journey home! ✈️ Let's stay inspired and take forward all the knowledge we gained. Till next time!

Congratulations to research fellow extraordinaire, Antonio Velez, on his superb presentation of our NCI-funded clinical trial of bronchoscopic Cryo-immunotherapy for advanced NSCLC! BCI proved safe, feasible and induced immune activation. Much more to learn! ⁦⁦ATS TO Assembly⁩

Brace yourself for a day packed with presentations & posters American Thoracic Society (ATS) #ATS2024 ! Catch us if you can!😉

#MedEd #Covid19 #Microbiome #Lungtransplant #PCCM #NTM #LungCancer

Exciting new research from NCARD's Prof. Y C Gary Lee & colleagues in The Lancet Respiratory Medicine advocating for expanded intrapleural trials to address the unmet needs of early-stage #mesothelioma patients. Read more: sciencedirect.com/science/articl…
#Asbestosresearch #CancerResearch

Fantastic teaching presentation by future NYULangonePCCSM faculty member Marwah Ibrahem! I thought loop gain was something to do with the kidney, but clearly needed to learn!

Starting the week on a strong note at American Thoracic Society (ATS) #ATS2024 ! Let's kick off the day's activities!

#Microbiome #COPD #Lungtransplant #COVID19 #Meded #PCCM

No Sunday Scaries here! We have a busy day ahead American Thoracic Society (ATS) #ATS2024 !

#COVID19 #Lungcancer #Lungtransplant #Sarcoidosis #PCCM #Meded

We're we're joining SCCM and wearing blue today in recognition of Critical Care Awareness month and in support of #criticalcare clinicians worldwide!

#NCCARM #CritCareMonth #WearBlue

Congrats to the NYU Grossman School of Medicine Class of 2024! 🎓🎉

This week's commencement at Carnegie Hall celebrated 109 new physicians heading into 22 specialties, with 18 graduates completing the three-year MD pathway. See highlights here: nyulangone.org/news/class-202…

American Thoracic Society (ATS) #ATS2024 starts in only a few days! Follow along to see where our faculty, staff, and trainees will be during the conference.

Be sure to check out our booth in the exhibit hall and tag @nyulangonepccsm on Twitter and Instagram! See our schedule (4/4)👇

Bills 2024 schedule ⬇️

Congratulations to you and colleagues on this monumental effort and landmark clinical trial! #mesothelioma

MARS-2 now The Lancet Respiratory Medicine, Dr Eric Lim et al. Phase 3 trial of extended pleurectomy decortication then chemo vs chemo alone in pleural #mesothelioma . Survival 19.3m with surgery and 24.8m with no surgery. Surgery arm also had more serious adverse events.
thelancet.com/journals/lanre…

Incredible opportunity to lead the Adult Cystic Fibrosis Program at the #3 ranked Pulmonology and Lung Surgery Program in the United States! apply.interfolio.com/145682

I am privileged to be among this remarkable group of investigators exploring novel therapies for #mesothelioma .